Hemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Not manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mOnly biotechwith 2 Myron'son theleadershipteamI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetAnymentionof Mino-WrapMyron Holubiakand I founded aprivatecompany in2013We had aphase 2btrial with100%efficacyThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mI/ONTAKis our leadassetAn actualiMSCupdateI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Not manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mOnly biotechwith 2 Myron'son theleadershipteamI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetAnymentionof Mino-WrapMyron Holubiakand I founded aprivatecompany in2013We had aphase 2btrial with100%efficacyThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mI/ONTAKis our leadassetAn actualiMSCupdateI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Hemorrhoids is a $2B market
  2. I/ONTAK was the best deal I ever made
  3. We intend to submit a BLA in 2H 2022
  4. Not many companies this size with 2 late stage assets
  5. We have enough cash to go well into 2023
  6. We will open up international sites for Mino-Lok trial
  7. I won't dilute shareholders
  8. Our Halo-Lido trial will have final patient by end of 2022
  9. We will have exclusivity
  10. I/ONTAK's potential market is >$300m
  11. Only biotech with 2 Myron's on the leadership team
  12. I'm a shareholder myself
  13. There are no FDA approved drugs to treat hemorrhoids
  14. Mino-Lok is our lead asset
  15. Any mention of Mino-Wrap
  16. Myron Holubiak and I founded a private company in 2013
  17. We had a phase 2b trial with 100% efficacy
  18. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  19. Mino-Lok potential market >$1B
  20. We expect to finish the Mino-Lok trial this year
  21. Insiders invested $26.5m
  22. I/ONTAK is our lead asset
  23. An actual iMSC update
  24. I/ONTAK was previously approved but taken off the market to improve manufacturing.